Key facts
- This page summarizes Kevin Bitterman's Form 4 filing for Akero Therapeutics, Inc. (AKRO).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jun 2021, 20:07.
Kevin Bitterman - 01 Jun 2021 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)
- Reporting relationship
- Director
- Issuer ticker
- AKRO
- Reported as of
- 01 Jun 2021
- Net transaction value
- -$459,611
- SEC form
- 4
- Accepted by SEC
- 03 Jun 2021, 20:07:04 UTC
- Next SEC filing
- 03 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kevin Bitterman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kevin Bitterman filed Form 4 for Akero Therapeutics, Inc. (AKRO) on 03 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$459,611.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AKRO
transaction
Common Stock
Sale
- Transaction value
- $434,776
- Shares
- -16,544
- Change %
- -100%
- Price
- $26.28
- Shares after
- 0
- Date
- 01 Jun 2021
- Ownership
- See footnote
- Footnotes
- F1, F2, F3, F4
AKRO
transaction
Common Stock
Sale
- Transaction value
- $24,835
- Shares
- -945
- Change %
- -100%
- Price
- $26.28
- Shares after
- 0
- Date
- 01 Jun 2021
- Ownership
- See footnote
- Footnotes
- F1, F2, F3, F5
AKRO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,963,529
- Date
- 01 Jun 2021
- Ownership
- See footnote
- Footnotes
- F2, F6
AKRO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 268,722
- Date
- 01 Jun 2021
- Ownership
- See footnote
- Footnotes
- F2, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Shares were sold pursuant to a Rule 10b5-1 trading plan.
Footnote F2
The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund XI, L.P. ("AVF XI") and Atlas Venture Opportunity Fund I, L.P. ("AVOF") for no additional consideration to their respective limited and general partners, including Atlas Venture Associates XI, LP ("AVA XI LP") and Atlas Venture Associates Opportunity I, LLC ("AVAO LP"). As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.73 to $26.67 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
These shares are owned directly by AVA XI LP. Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVA XI LP. The Reporting Person is a member of AVA XI LLC and disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any.
Footnote F5
These shares are owned directly by AVAO LP. Atlas Venture Associates Opportunity I, LLC ("AVAO LLC") is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any.
Footnote F6
These shares are owned directly by AVF XI. AVA XI LP is the general partner of AVF XI. AVA XI LLC is the general partner of AVA XI LP. The Reporting Person is a member of AVA XI LLC and disclaims Section 16 beneficial ownership of the securities held by AVF XI, except to the extent of his pecuniary interest therein, if any.
Footnote F7
These shares are owned directly by AVOF. AVAO LP is the general partner of AVOF. AVAO LLC is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of the securities held by AVOF, except to the extent of his pecuniary interest therein, if any.